Pee Cee Cosma Sope Limited (PCCOSMA.BO)
INR 592.3
(0.75%)
INR 592.3
(0.75%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 80.17 Million INR | -51.05% |
| 2022 | 163.8 Million INR | -14.35% |
| 2021 | 191.24 Million INR | 121.07% |
| 2020 | 86.5 Million INR | -9.66% |
| 2019 | 95.76 Million INR | 33.01% |
| 2018 | 71.99 Million INR | 12.6% |
| 2017 | 63.93 Million INR | -19.91% |
| 2016 | 79.83 Million INR | -20.45% |
| 2015 | 100.35 Million INR | -26.47% |
| 2014 | 136.47 Million INR | 22.76% |
| 2013 | 111.17 Million INR | -0.84% |
| 2012 | 112.11 Million INR | 28.49% |
| 2011 | 87.25 Million INR | 137.88% |
| 2010 | 36.68 Million INR | -31.65% |
| 2009 | 53.66 Million INR | -44.42% |
| 2008 | 96.55 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 80.17 Million INR | 0.0% |
| 2023 FY | 80.17 Million INR | -51.05% |
| 2023 Q2 | 152.09 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 163.8 Million INR | -14.35% |
| 2022 Q4 | 163.8 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 196.57 Million INR | 0.0% |
| 2021 Q2 | 141.13 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 191.24 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 191.24 Million INR | 121.07% |
| 2020 Q2 | 88.15 Million INR | 0.0% |
| 2020 FY | 86.5 Million INR | -9.66% |
| 2020 Q4 | 86.5 Million INR | 0.0% |
| 2019 FY | 95.76 Million INR | 33.01% |
| 2019 Q2 | 98.02 Million INR | 0.0% |
| 2019 Q4 | 95.76 Million INR | 0.0% |
| 2018 FY | 71.99 Million INR | 12.6% |
| 2018 Q2 | 70.61 Million INR | 0.0% |
| 2018 Q4 | 71.99 Million INR | 0.0% |
| 2017 Q4 | 63.88 Million INR | 0.0% |
| 2017 Q2 | 77.41 Million INR | 0.0% |
| 2017 FY | 63.93 Million INR | -19.91% |
| 2016 Q2 | 97.79 Million INR | 0.0% |
| 2016 FY | 79.83 Million INR | -20.45% |
| 2016 Q4 | 87.79 Million INR | 0.0% |
| 2015 FY | 100.35 Million INR | -26.47% |
| 2015 Q4 | 100.35 Million INR | 0.0% |
| 2015 Q2 | 109.06 Million INR | 0.0% |
| 2014 Q4 | 136.47 Million INR | 0.0% |
| 2014 Q2 | 110.73 Million INR | 0.0% |
| 2014 FY | 136.47 Million INR | 22.76% |
| 2013 Q2 | 93.77 Million INR | 0.0% |
| 2013 Q4 | 111.17 Million INR | 0.0% |
| 2013 FY | 111.17 Million INR | -0.84% |
| 2012 Q4 | 112.11 Million INR | 0.0% |
| 2012 FY | 112.11 Million INR | 28.49% |
| 2011 Q4 | 87.25 Million INR | 0.0% |
| 2011 FY | 87.25 Million INR | 137.88% |
| 2010 FY | 36.68 Million INR | -31.65% |
| 2009 FY | 53.66 Million INR | -44.42% |
| 2008 FY | 96.55 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Ador Multiproducts Limited | 28.52 Million INR | -181.054% |
| Ambica Agarbathies Aroma & Industries Limited | 1.09 Billion INR | 92.71% |
| Bajaj Consumer Care Limited | 1.53 Billion INR | 94.76% |
| Colgate-Palmolive (India) Limited | 13.22 Billion INR | 99.394% |
| Cupid Limited | 186.52 Million INR | 57.015% |
| Dabur India Limited | 48.19 Billion INR | 99.834% |
| Emami Limited | 8.21 Billion INR | 99.025% |
| Gillette India Limited | 8.59 Billion INR | 99.067% |
| Godrej Consumer Products Limited | 58.97 Billion INR | 99.864% |
| Hindustan Unilever Limited | 270.76 Billion INR | 99.97% |
| Hipolin Limited | 48.57 Million INR | -65.069% |
| Honasa Consumer Limited | 5.36 Billion INR | 98.506% |
| JHS Svendgaard Laboratories Limited | 271.7 Million INR | 70.491% |
| Jyothy Labs Limited | 5.9 Billion INR | 98.643% |
| Kaya Limited | 5.22 Billion INR | 98.465% |
| Marico Limited | 32.52 Billion INR | 99.753% |
| N.K Industries Limited | 22.4 Billion INR | 99.642% |
| PAOS INDUSTRIES LIMITED | 163.96 Million INR | 51.101% |
| Paramount Cosmetics (India) Limited | 205.72 Million INR | 61.026% |
| Procter & Gamble Hygiene and Health Care Limited | 10.83 Billion INR | 99.26% |